Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
- 1 October 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 117 (4), 838-847
- https://doi.org/10.1016/s0016-5085(99)70342-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Prostaglandin H Synthase Expression Is Variable in Human Colorectal Adenocarcinoma Cell LinesExperimental Cell Research, 1997
- Lovastatin-Induced Apoptosis in Prostate Stromal CellsJournal of Clinical Endocrinology & Metabolism, 1997
- The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and dna production of rat hepatocytesLife Sciences, 1996
- Increased Intestinal Bak Expression Results in ApoptosisBiochemical and Biophysical Research Communications, 1996
- SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouseCarcinogenesis: Integrative Cancer Research, 1996
- Lovastatin Inhibits Proliferation and Differentiation and Causes Apoptosis in Lipopolysaccharide-Stimulated Murine B CellsBiochemical and Biophysical Research Communications, 1995
- Lovastatin Induces Growth Inhibition and Apoptosis in Human Malignant Glioma CellsBiochemical and Biophysical Research Communications, 1994
- Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 CellsBiochemical and Biophysical Research Communications, 1994
- Regulation of the mevalonate pathwayNature, 1990
- Influence of various prostaglandin synthesis inhibitors on DMH-induced rat colon cancerDiseases of the Colon & Rectum, 1984